Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines

Stem Cell Reports

Volumn 4, Issue 5, 2015, Pages 847-859

  Shaltouki, Atossa ^a   Sivapatham, Renuka ^a   Pei, Ying ^a   Gerencser, Akos A ^a   Momčilović, Olga ^a   Rao, Mahendra S ^b   Zeng, Xianmin ^a,c  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b NxCell Inc   (United States)

^c XCell Science Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN; MITOCHONDRIAL DNA; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRESS; CELL VOLUME; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRIAL VOLUME; MITOCHONDRION; NERVE CELL; PARKINSON DISEASE; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; CYTOLOGY; DEFICIENCY; GENETICS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELL; KARYOTYPING; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DNA, MITOCHONDRIAL; DOPAMINERGIC NEURONS; HUMANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; MITOCHONDRIA; MUTATION; PARKINSON DISEASE; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84929273586     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2015.02.019     Document Type: Article

References (63)

1. N. Abbas, C.B. Lücking, S. Ricard, A. Dürr, V. Bonifati, G. De Michele, S. Bouley, J.R. Vaughan, T. Gasser, R. Marconi French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe Hum. Mol. Genet. 8 1999 567 574
2. R.S. Akundi, L. Zhi, P.G. Sullivan, and H. Büeler Shared and cell type-specific mitochondrial defects and metabolic adaptations in primary cells from PINK1-deficient mice Neurodegener. Dis. 12 2013 136 149
3. S. Anderson, A.T. Bankier, B.G. Barrell, M.H. de Bruijn, A.R. Coulson, J. Drouin, I.C. Eperon, D.P. Nierlich, B.A. Roe, and F. Sanger Sequence and organization of the human mitochondrial genome Nature 290 1981 457 465
4. M.J. Birket, A.L. Orr, A.A. Gerencser, D.T. Madden, C. Vitelli, A. Swistowski, M.D. Brand, and X. Zeng A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells J. Cell Sci. 124 2011 348 358
5. J.L. Burman, S. Yu, A.C. Poole, R.B. Decal, and L. Pallanck Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants Proc. Natl. Acad. Sci. USA 109 2012 10438 10443
6. T. Cathomen, and J.K. Joung Zinc-finger nucleases: the next generation emerges Mol. Ther. 16 2008 1200 1207
7. C. Chauvin, F. De Oliveira, X. Ronot, M. Mousseau, X. Leverve, and E. Fontaine Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells J. Biol. Chem. 276 2001 41394 41398
8. H. Chen, and D.C. Chan Mitochondrial dynamics - fusion, fission, movement, and mitophagy - in neurodegenerative diseases Hum. Mol. Genet. 18 R2 2009 R169 R176
9. Y. Chu, and J.H. Kordower Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Neurobiol. Dis. 25 2007 134 149
10. K.K. Chung, Y. Zhang, K.L. Lim, Y. Tanaka, H. Huang, J. Gao, C.A. Ross, V.L. Dawson, and T.M. Dawson Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Nat. Med. 7 2001 1144 1150
11. I.E. Clark, M.W. Dodson, C. Jiang, J.H. Cao, J.R. Huh, J.H. Seol, S.J. Yoo, B.A. Hay, and M. Guo Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin Nature 441 2006 1162 1166
12. C.A. da Costa, C. Sunyach, E. Giaime, A. West, O. Corti, A. Brice, S. Safe, P.M. Abou-Sleiman, N.W. Wood, and H. Takahashi Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease Nat. Cell Biol. 11 2009 1370 1375
13. J.C. Dächsel, S.J. Lincoln, J. Gonzalez, O.A. Ross, D.W. Dickson, and M.J. Farrer The ups and downs of alpha-synuclein mRNA expression Mov. Disord. 22 2007 293 295
14. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
15. T.M. Dawson Parkin and defective ubiquitination in Parkinson's disease J. Neural Transm. Suppl. 7 2006 209 213
16. T.M. Dawson, H.S. Ko, and V.L. Dawson Genetic animal models of Parkinson's disease Neuron 66 2010 646 661
17. M.I. Ekstrand, M. Terzioglu, D. Galter, S. Zhu, C. Hofstetter, E. Lindqvist, S. Thams, A. Bergstrand, F.S. Hansson, and A. Trifunovic Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons Proc. Natl. Acad. Sci. USA 104 2007 1325 1330
18. N. Exner, A.K. Lutz, C. Haass, and K.F. Winklhofer Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences EMBO J. 31 2012 3038 3062
19. S. Geisler, K.M. Holmström, D. Skujat, F.C. Fiesel, O.C. Rothfuss, P.J. Kahle, and W. Springer PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 Nat. Cell Biol. 12 2010 119 131
20. A.A. Gerencser, C. Chinopoulos, M.J. Birket, M. Jastroch, C. Vitelli, D.G. Nicholls, and M.D. Brand Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium-induced de- and hyperpolarization of neuronal mitochondria J. Physiol. 590 2012 2845 2871
21. M.S. Goldberg, S.M. Fleming, J.J. Palacino, C. Cepeda, H.A. Lam, A. Bhatnagar, E.G. Meloni, N. Wu, L.C. Ackerson, and G.J. Klapstein Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J. Biol. Chem. 278 2003 43628 43635
22. J.C. Greene, A.J. Whitworth, I. Kuo, L.A. Andrews, M.B. Feany, and L.J. Pallanck Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants Proc. Natl. Acad. Sci. USA 100 2003 4078 4083
23. C. Henchcliffe, and M.F. Beal Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat. Clin. Pract. Neurol. 4 2008 600 609
24. Y. Imaizumi, Y. Okada, W. Akamatsu, M. Koike, N. Kuzumaki, H. Hayakawa, T. Nihira, T. Kobayashi, M. Ohyama, and S. Sato Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue Mol. Brain 5 2012 35
25. H. Jiang, Y. Ren, E.Y. Yuen, P. Zhong, M. Ghaedi, Z. Hu, G. Azabdaftari, K. Nakaso, Z. Yan, and J. Feng Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells Nat Commun 3 2012 668
26. D.R. Johns Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease N. Engl. J. Med. 333 1995 638 644
27. Y. Kim, J. Park, S. Kim, S. Song, S.K. Kwon, S.H. Lee, T. Kitada, J.M. Kim, and J. Chung PINK1 controls mitochondrial localization of Parkin through direct phosphorylation Biochem. Biophys. Res. Commun. 377 2008 975 980
28. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M. Yokochi, Y. Mizuno, and N. Shimizu Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
29. R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J.T. Epplen, L. Schöls, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
30. Y.J. Lee, S.Y. Jeong, M. Karbowski, C.L. Smith, and R.J. Youle Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis Mol. Biol. Cell 15 2004 5001 5011
31. K.L. Lim, K.C. Chew, J.M. Tan, C. Wang, K.K. Chung, Y. Zhang, Y. Tanaka, W. Smith, S. Engelender, and C.A. Ross Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation J. Neurosci. 25 2005 2002 2009
32. T.K. Lin, C.H. Cheng, S.D. Chen, C.W. Liou, C.R. Huang, and Y.C. Chuang Mitochondrial Dysfunction and Oxidative Stress Promote Apoptotic Cell Death in the Striatum via Cytochrome c/Caspase-3 Signaling Cascade Following Chronic Rotenone Intoxication in Rats Int. J. Mol. Sci. 13 2012 8722 8739
33. Q. Liu, O.Z. Pedersen, J. Peng, L.A. Couture, M.S. Rao, and X. Zeng Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation Cytotherapy 15 2013 999 1010
34. O. Momčilović, Q. Liu, A. Swistowski, T. Russo-Tait, Y. Zhao, M.S. Rao, and X. Zeng Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells Stem Cells Dev. 23 2014 406 420
35. H. Mortiboys, K.J. Thomas, W.J. Koopman, S. Klaffke, P. Abou-Sleiman, S. Olpin, N.W. Wood, P.H. Willems, J.A. Smeitink, M.R. Cookson, and O. Bandmann Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts Ann. Neurol. 64 2008 555 565
36. A. Panov, S. Dikalov, N. Shalbuyeva, G. Taylor, T. Sherer, and J.T. Greenamyre Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication J. Biol. Chem. 280 2005 42026 42035
37. N.P. Pavletich, and C.O. Pabo Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A Science 252 1991 809 817
38. C. Perier, A. Bender, E. García-Arumí, M.J. Melià, J. Bové, C. Laub, T. Klopstock, M. Elstner, R.B. Mounsey, and P. Teismann Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms Brain 136 2013 2369 2378
39. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, and R. Boyer Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
40. A. Reeve, M. Meagher, N. Lax, E. Simcox, P. Hepplewhite, E. Jaros, and D. Turnbull The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons J. Neurosci. 33 2013 10790 10801
41. O. Rothfuss, H. Fischer, T. Hasegawa, M. Maisel, P. Leitner, F. Miesel, M. Sharma, A. Bornemann, D. Berg, T. Gasser, and N. Patenge Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair Hum. Mol. Genet. 18 2009 3832 3850
42. A.H. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269
43. T.B. Sherer, R. Betarbet, C.M. Testa, B.B. Seo, J.R. Richardson, J.H. Kim, G.W. Miller, T. Yagi, A. Matsuno-Yagi, and J.T. Greenamyre Mechanism of toxicity in rotenone models of Parkinson's disease J. Neurosci. 23 2003 10756 10764
44. T.B. Sherer, J.H. Kim, R. Betarbet, and J.T. Greenamyre Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Exp. Neurol. 179 2003 9 16
45. K. Shiba-Fukushima, Y. Imai, S. Yoshida, Y. Ishihama, T. Kanao, S. Sato, and N. Hattori PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy Sci Rep 2 2012 1002
46. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, and R. Nussbaum alpha-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
47. D. Sulzer Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease Trends Neurosci. 30 2007 244 250
48. A. Swistowski, J. Peng, Y. Han, A.M. Swistowska, M.S. Rao, and X. Zeng Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them PLoS ONE 4 2009 e6233
49. K. Tanaka, T. Suzuki, N. Hattori, and Y. Mizuno Ubiquitin, proteasome and parkin Biochim. Biophys. Acta 1695 2004 235 247
50. C.M. Testa, T.B. Sherer, and J.T. Greenamyre Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures Brain Res. Mol. Brain Res. 134 2005 109 118
51. Y.C. Tsai, P.S. Fishman, N.V. Thakor, and G.A. Oyler Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function J. Biol. Chem. 278 2003 22044 22055
52. F.D. Urnov, E.J. Rebar, M.C. Holmes, H.S. Zhang, and P.D. Gregory Genome editing with engineered zinc finger nucleases Nat. Rev. Genet. 11 2010 636 646
53. A.M. van der Bliek, Q. Shen, and S. Kawajiri Mechanisms of mitochondrial fission and fusion Cold Spring Harb. Perspect. Biol. 5 2013
54. M. Vila, D. Ramonet, and C. Perier Mitochondrial alterations in Parkinson's disease: new clues J. Neurochem. 107 2008 317 328
55. T. Wang, E. Choi, M.C. Monaco, E. Campanac, M. Medynets, T. Do, P. Rao, K.R. Johnson, A.G. Elkahloun, and G. Von Geldern Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation PLoS ONE 8 2013 e81720
56. Y.H. Wei Mitochondrial DNA mutations and oxidative damage in aging and diseases: an emerging paradigm of gerontology and medicine Proc. Natl. Sci. Counc. Repub. China B 22 1998 55 67
57. A. Wong, and G. Cortopassi Reproducible quantitative PCR of mitochondrial and nuclear DNA copy number using the LightCycler Methods Mol. Biol. 197 2002 129 138
58. N. Yadava, and D.G. Nicholls Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone J. Neurosci. 27 2007 7310 7317
59. Yang, W., Mills, J.A., Sullivan, S., Liu, Y., French, D.L., and Gadue, P. (2008). iPSC Reprogramming from Human Peripheral Blood Using Sendai Virus Mediated Gene Transfer. http://www.stembook.org/sites/default/files/protocols/iPSC-Reprogramming-from-Human-Peripheral-Blood-0.pdf.
60. J.J. Zarranz, J. Alegre, J.C. Gómez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, and B. Atarés The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173
61. X. Zeng, J. Chen, J.F. Sanchez, M. Coggiano, O. Dillon-Carter, J. Petersen, and W.J. Freed Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation Stem Cells 21 2003 647 653
62. X. Zeng, J.G. Hunsberger, A. Simeonov, N. Malik, Y. Pei, and M. Rao Concise review: modeling central nervous system diseases using induced pluripotent stem cells Stem Cells Transl Med 3 2014 1418 1428
63. Y. Zhang, H. Ma, B. Xie, C. Han, C. Wang, H. Qing, and Y. Deng Alpha-synuclein overexpression induced mitochondrial damage by the generation of endogenous neurotoxins in PC12 cells Neurosci. Lett. 547 2013 65 69